A New Cost-Effectiveness Framework for Modeling Psoriatic Arthritis Treatments

Value in Health - United Kingdom
doi 10.1016/j.jval.2016.03.1151
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Psoriatic Arthritis: A Permanent New Challenge for Dermatologists (Review)

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

PMS13 Cost-Effectiveness of Biological Treatments in Patients With Rheumatoid Arthritis in Taiwan

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Cost-Effectiveness of Certolizumab Pegol in the Treatment of Active Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis in Romania

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Pms38 - Cost Effectiveness Analysis of Secukinumab Versus Ustekinumab for the Treatment of Psoriatic Arthritis in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

PSY32 Modeling Cost-Effectiveness of Drug Treatments for Severe Chronic Non-Cancer Pain in Portugal

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

Cost Effectiveness of Hepatitis C Treatments: Need for a Comprehensive Evaluation

Kaohsiung Journal of Medical Sciences
Medicine
2017English

Pms54 - Cost-Effectiveness Analysis of Etanercept as First Line of Treatment in Colombian Patients With Psoriatic Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psoriatic Arthritis

2019English

Psoriatic Arthritis

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy